The Patent Finder

Myriad Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Myriad Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Myriad Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,595,401Therapeutic Compounds and Their Use in Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,476,285Purine-Core Inhibitors of HSP90 and Their Use in Treating Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,505,800Extended triterpene derivatives
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,653,139Drug substance preparations, pharmaceutical compositions and dosage forms
Formerly held
Lapsed on the fee record
Ended Feb 18, 2026 · USPTO record
Lapsed on the fee recordEnded Feb 18, 2026USPTO record
US 8,318,425Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
Formerly held
Term ended
Term ended Sep 11, 2024 · USPTO record
Term endedTerm ended Sep 11, 2024USPTO record
US 7,273,889Nmda Receptor Antagonist Formulation with Reduced Neurotoxicity
Formerly held
Term ended
Term ended Jul 10, 2023 · High confidence
Term endedTerm ended Jul 10, 2023High confidence
US 7,008,941Reverse-Turn Mimetics and Methods Relating Thereto
Formerly held
Term ended
Term ended May 26, 2023 · High confidence
Term endedTerm ended May 26, 2023High confidence
US 6,943,157Reverse-Turn Mimetics and Composition and Methods Relating Thereto
Formerly held
Term ended
Term ended Feb 27, 2023 · High confidence
Term endedTerm ended Feb 27, 2023High confidence
US 6,943,167Helix Mimetics and Composition and Methods Related Thereto
Formerly held
Term ended
Term ended Aug 29, 2022 · High confidence
Term endedTerm ended Aug 29, 2022High confidence
US 7,714,022Pyrrole Derivatives as Therapeutic Compounds
Formerly held
Lapsed on the fee record
Ended May 11, 2022 · High confidence
Lapsed on the fee recordEnded May 11, 2022High confidence
10 of 64 patents shown.
Pro members see all 64.
Pro members: see all 64 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited